StonvexLoading…
StonvexStonvexStonvexCore line items from CRSR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.47B | $1.32B | $1.46B | $1.38B |
Operating Income | $2.08M | $-49.95M | $9.69M | $-54.79M |
Net Income | $-16.16M | $-85.18M | $-2.59M | $-54.39M |
EPS (Diluted) | $-0.12 | $-0.95 | $0.03 | $-0.63 |
Total Assets | $1.25B | $1.24B | $1.36B | $1.30B |
Total Liabilities | $608.03M | $616.38M | $663.48M | $641.81M |
Cash & Equivalents | $98.83M | $109.63M | $178.56M | $154.06M |
Free Cash Flow OCF − CapEx | $34.75M | $26.03M | $76.39M | $40.07M |
Shares Outstanding | 106.64M | 104.76M | 103.25M | 101.39M |